Introduction
The National Centre for Epilepsy in Norway is a referral centre admitting patients with refractory epilepsy from the whole country. Most of the patients have used various antiepileptic drugs (AEDs) and drug combinations without achieving satisfactory seizure control. There are four wards for adolescents/adults, four wards for children aged 0-16 years, a neurodiagnostic department, a nursery school and a school for children [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] years of age at the premises; the goal being to offer comprehensive care to the patients.
The term comprehensive care implies to offer integrated multidisciplinary services, including physical, social, and vocational habilitation and rehabilitation, and if required, patients may attend school. 1 About 30% of patients with epilepsy will be in need of comprehensive care at a referral centre where they can stay for a longer time than in ordinary hospital wards. The specialists in paediatrics or neurology who establish the diagnosis of epilepsy and initiate drug therapy should cooperate closely with the local general practitioner, nurse, social worker, school teachers and psychologist if necessary. 1 The situation for many of these children with epilepsy is complicated, and the follow-up of many of the individual patients is often difficult.
The purpose of the present study was to investigate the characteristics of children admitted to a referral centre for epilepsy, and the use of AEDs in these children, as studied by data from the medical records. We also wanted to study the impact of the stay, where focus is on optimalized pharmacological treatment, along with integrated multidisciplinary services, as Seizure 18 (2009) [573] [574] [575] [576] [577] [578] [579] evaluated by the parents three months after the children were discharged from the centre.
Materials and methods
The study comprised children admitted to the National Centre for Epilepsy from August to December 2006. Children discharged with at least one AED were included in the study. If the child was admitted more than once during the period, only data from the last admission were recorded. Demographic and clinical data were collected from medical records at the centre, including year of birth, gender, reason for admission, seizure types and data regarding the use of AEDs. The registered epilepsy diagnoses and seizure types in the medical records were grouped based on the International classification system ICD-10: focal epilepsies included the diagnosis categories G40.0, G40.1 and G40.2 and generalized/multifocal epilepsies G40.3 and G40.4. G40.8 consisted of epilepsy and epileptic syndromes undetermined as to whether they were focal or generalized, mostly sleep-induced epilepsy, but also including LandauKleffner syndrome (LKS), epilepsy with continuous spike wave during sleep (CSWS), and unspecified epilepsies included G40.6, G40.7, G40.9 and other. 2 A questionnaire was sent to the parents three months after discharge. Two hundred and sixty one children, 153 boys and 108 girls were included. In the questionnaire the parents answered both closed and open questions; first what medication the child currently was using and whether that medication was the same as at discharge from the centre. Then, whether the seizure situation was better, worse or unchanged, and in more detail the number of seizures each day or week and how long they lasted, before and after admission to the centre, according to the patients' seizure diaries. There were also questions regarding adverse effects before and after admission, and lastly, they were asked whether they found everyday life better, worse or unchanged after the stay at the centre. A reminder was sent once to those who did not reply at the first receipt. 157 of the 261 questionnaires (60%) were answered and returned. All data were anonymized, by giving each form a number. The study was approved by the local ethical committee, as a part of the quality assurance at the centre.
Results

Patient population
Patient characteristics are shown in Tables 1 and 2 . The mean number of days at the centre was not influenced by the seizure type (9-10 days for patients in all four groups of epilepsies).
Mainly due to the short-stay ward, but also at the other wards, children were frequently re-admitted. The hospital policy is to offer frequent stays to the patients rather than one prolonged stay. In 2006 there were 549 admissions of children, of those 223 were re-admissions.
The youngest children more often had generalized/multifocal or unspecified epilepsies while the oldest children most often had focal epilepsies ( Table 2 ). The majority of the children were admitted due to unsatisfactory seizure control and for drug adjustments, including both change of drug and/or change of dose (48%). Other reasons for admission included diagnostic evaluation (36%), in most cases with EEG-monitoring (standard, ambulatory, or long-term video-EEG) and post-surgical evaluation (13%). Eight percent were admitted for a psychological and pedagogical elucidation, seven percent for evaluation for possible epilepsy surgery or vagal nerve stimulation, and 12% for other reasons (including ketogenic diet, follow-up of vagal nerve stimulation and steroid treatment). The most common reasons for admission according to the various seizure types are given in Table 2 .
Clinical use of antiepileptic drugs
New vs. old AEDs
Comparison was made between AEDs used by the children at admission, at discharge and three months after discharge, based on data from the medical records and the answers from the questionnaire (Fig. 1) . Levetiracetam, valproate and lamotrigine were the most frequently used AEDs, before, during and after the stay at the centre. Levetiracetam was the only drug being more frequently used at discharge/three months after discharge than at admission. Levetiracetam was predominantly used in epilepsy and epileptic syndromes undetermined as to whether they were focal or generalized such as sleep-induced epilepsy (the majority), LKS and epilepsy with CSWS (76% of the patients). Levetiracetam was used in about 30% of patients with focal and generalized/multifocal epilepsies and in 14% with unspecified epilepsies at discharge (Fig. 2) . Both valproate and lamotrigine were used in all epilepsy types, but most often in focal and unspecified epilepsies. Other interesting findings were that oxcarbazepine was predominantly used in focal epilepsies, and zonisamide was mostly used in generalized/multifocal epilepsies. Less than 10 patients used sulthiame, vigabatrin, phenytoin and acetazolamide, and no patients used ethosuximide and phenobarbital at discharge. Based on the data presented in Fig. 2 , new AEDs were used much more frequently than older AEDs, totally 251 and 158 times, respectively. It was noted that most patients used more than one AED (see Section 3.2.4). New AEDs are defined as drugs marketed after 1990 and include lamotrigine, levetiracetam, oxcarbazepine, topiramate, vigabatrin and zonisamide. According to the various seizure types, new AEDs were preferred in all seizure types except unspecified ( Table 2 ). There were no differences in the type of AEDs used at discharge between the children whose parents answered the questionnaire and the total population (data not shown). Fig. 3 shows the most frequently used AEDs in different age groups at discharge from the centre (n = 261). Levetiracetam was used less frequently in the younger age groups (13%) compared to in the older age groups (40%). Valproate was used in 50% of the youngest children compared to 30% in the groups from 4 to 11 years old and only in 15% in the oldest age group (12-16 years old). Lamotrigine was used in 13% of the youngest children, in 24% from 4 to 7 years old and in 30% of the children from 8 to 16 years old. Clonazepam was frequently used in the youngest children (30%), less than 10% in the older children and not at all in the oldest children. Topiramate was used in 27% of the youngest children and less frequently in the older age groups (7-15%). The use of oxcarbazepine and carbamazepine was minor in the three youngest age groups, but was used in 10% and 20% of the oldest children, respectively.
Age
Based on the results presented in Fig. 3 , the youngest children used older AEDs more frequently than newer AEDs, in 37 and 21 cases, respectively. In children 4-7 and 8-11 years old, new AEDs were used most frequently, 69 and 89 times, respectively, while older drugs were used 61 and 59 times, respectively. In the oldest children, new AEDs were used predominantly, 52 times compared to 29 times. Note that many of the children used more than one AED.
TDM
Therapeutic drug monitoring (TDM) is implemented for the follow-up of the pharmacological treatment of all patients at the centre. The mean serum concentrations compared to the reference ranges for the various drugs are shown in Table 3 . The mean concentrations are below the reference range for zonisamide and clonazepam, while they are in the middle for carbamazepine and valproate. For the other AEDs the mean serum concentrations are low, but within the reference ranges.
Of the 261 patients, 31 patients started with a new AED, 26 patients stopped using one or two AEDs, and 16 patients switched Use of AEDs at admission, discharge and three months after discharge from the epilepsy centre based on data from the medical journal and answers from the questionnaire (n = 157). from one AED to another. Levetiracetam treatment was initiated in 17 patients. In 10 cases the treatment was added to the AEDs the children were already using, and in seven of them it was switched from valproate, lamotrigine or clobazam. Extensive dosage adjustments were carried out during the stay, including dosage titration during initiation and withdrawal of a drug. For the new AEDs levetiracetam, topiramate, oxcarbazepine and zonisamide, the dosages were increased to a much larger extent than the number of reductions, while valproate and clonazepam dosages were predominantly reduced. In total, dosage adjustments were made 189 times in 130 of 157 patients (83%) -from one to four adjustments in one patient -following measurement of serum concentrations and clinical consideration. In addition, further recommendations for dosage adjustments after discharge were made in 52 cases.
Polytherapy
The majority of the patients were using one or two AEDs both at admission and at discharge: the medical records showed that 114 and 120 children used one AED at admission and discharge, respectively, while 101 and 104 children used two AEDs, respectively. Thirty-two patients were using three AEDs both at admission and at discharge, while six were using four at admission and five at discharge. At admission, eight children did not use any AEDs, but all children were discharged with at least one AED (as that was one of the inclusion criteria). Two hundred and nine children (80%) used the same number of AEDs at admission compared to at discharge, 30 children used more AEDs (12%) and 22 children used less AEDs (8%) at discharge from the centre. There were 14 different AEDs in use, as shown in Figs. 2 and 3 . There were more parents of children who used polytherapy that did not return the questionnaire (63% vs. 54%).
Adverse effects
The parents were asked about adverse effects thought to be due to AEDs before admission to the centre, and three months after discharge. These questions were open, and 54 different adverse effects were reported. They were grouped into categories, and the ten most frequently reported adverse effects before and after admission are listed in Fig. 4 , where behavioural changes, somnolence and drowsiness were reported most frequently. There was a tendency that the more serious adverse effects affecting cognition were less pronounced after discharge. The number of adverse effects was reduced by 20%; 47% and 37% of the patients experienced side effects before and after the stay at the centre, respectively.
Seizure control and everyday life
According to the questionnaires, twenty-three patients (15%) became seizure free after the stay at the centre. The group of patients with several seizures every day was reduced by 25%, from 56 to 43 patients. Forty-three patients (27%) had fewer/less serious seizures after the stay. Reduction in seizure frequency or seizure freedom was independent of epilepsy diagnosis.
According to the parents' subjective view and their seizure diaries, 40% of the children experienced a better seizure situation regarding duration and severity of seizures, and 47% of the families experienced a better everyday life after the stay at the centre. 12 patients experienced aggravation of seizures, and seven a worsening of everyday life. The use of AEDs, i.e. practical considerations and compliance, was unchanged in a majority of the cases.
Comorbid conditions and concomitant medication
Two-thirds of the children (177 out of 261) suffered from comorbid conditions; they had 1-5 other diagnosis than epilepsy. Of these patients, 47% had one comorbid condition, 36% had two and 17% had three or more comorbid conditions. The most commonly occurring comorbid conditions were developmental disorders (15%) and attention deficit hyperactivity disorder (ADHD) (10%) ( Table 4 ). According to the various epilepsy types, 76% of patients with generalized/multifocal epilepsy suffered from comorbid conditions, 70% of the patients with focal epilepsy, and 58 and 60% of the patients with epilepsies undetermined as to whether they were focal or generalized, and unspecified epilepsies, respectively (Table 2) .
One-third of the patients were also taking other drugs in addition to AEDs; hypnotics/sedatives including melatonin, centrally acting sympathomimetics, drugs for obstructive airway diseases or antihistamines (Table 4) . Laxatives, drugs for gastro-oesophageal reflux and dietary supplements were used by less than 10%. Other medications used by four or fewer children were antibiotics, desmopressin, cortisone, levothyroxine, analgesics, antimigraine preparations, antipsychotics and diuretics. a The mean serum concentrations are given with range in parenthesis (n = 237).
The serum concentrations for nitrazepam were not obtained, and the AEDs measured in less than 4 children are not presented (acetazolamide, ethosuximide, sulthiame, vigabatrin). b [14] [15] [16] . Fig. 4 . The ten most frequently reported adverse effects before and after the stay at the epilepsy centre (n = 157).
Discussion
Clinical use of AEDs
The results demonstrated that there was no difference in the total use of the various AEDs after admission to the centre, but dosage adjustments were made in the majority of the patients, and this includes also the patients who were titrated up and down with two AEDs for a period during a change of the medication. The reasons for admission also show that the pharmacological treatment is in focus, as half of the patients were admitted to the centre for changes in their medication.
New vs. old AEDs
Levetiracetam was the most commonly used AED before, during and after the stay at the centre, and it was the only drug more frequently used after discharge than at admission. Levetiracetam was marketed in 2001 and is the most commonly used newer AED at the centre at large. This differs from the country as a whole, as lamotrigine was the most commonly used AED in 2006 and carbamazepine the most commonly used AED from 1988 to 2005. It should be emphasized, however, that in the country as a whole, AEDs used in other indications, as in psychiatry, are also included. Levetiracetam was only the ninth most commonly used AED in 2006. 3 Earlier studies have demonstrated that levetiracetam could lead to seizure aggravation, both in adults and children, but following recommendations to use a lower initial dose and a slower dose escalation, these reactions have been avoided, and levetiracetam has proved to be an important contribution to the epilepsy treatment armamentarium. 4, 5 An interesting finding in our study was that levetiracetam predominantly was used in epilepsies without information of partial or generalized seizures (G40.8). This group includes children with sleep-induced epilepsy (the majority), and a small group of children with epilepsy syndromes such as LKS and epilepsy with CSWS. At our centre children with 30-90% epileptiform activity during slow wave sleep are classified within G40.8. These nocturnal interictal discharges not classified as CSWS are tentatively treated with levetiracetam at our centre. There are some reports concluding that children may benefit clinically from treatment of these interictal discharges. 6, 7 An earlier study, also including adults, has shown that newer AEDs are more frequently used at the centre than in the country as a whole. 8 Several studies have demonstrated that the new drugs are equally effective, have less side effects and a lower potential for interactions. [9] [10] [11] All of these qualities are important regarding treatment of children with severe epilepsy. The three most frequently used AEDs in our study, levetiracetam, valproate and lamotrigine, all have broad spectrum effects suitable in both focal and generalized epilepsies, used as monotherapy or as add-on. In addition, many of the AEDs have been investigated for the use in other CNS-related disorders that may occur as comorbid conditions, which should be taken into account when considering the optimal drug of choice for the individual patient. 12 
Age
The present study demonstrates that new AEDs were chosen more frequently than older drugs in all age groups except in the youngest children, and the group with unspecified epilepsies, which included many of the youngest children. This is probably due to the fact that the oldest children have already tried the old drugs without a satisfying result before admission, while the youngest have not yet reached to do so. Policy at our centre is still in most cases to try the old AEDs first. The use of valproate and benzodiazepines among the youngest children probably reflects their severe epilepsies with generalized/multifocal seizures, along with the somewhat conservative approach to old vs. new AEDs at the centre. Topiramate though, has been shown to be the drug of choice in refractory infantile spasms (West syndrome) when conventional drugs like adrenocorticotropic hormone (ACTH), vigabatrin and valproate failed before admission to the centre. 13 
TDM
TDM is implemented as a part of the comprehensive care approach to the treatment. Most often the serum concentrations of AEDs were low in the children, but within the reference ranges and dosage adjustments were made according to the measurements of serum concentrations and clinical efficacy. TDM is important for several reasons; to optimize the therapy with AEDs in the individual patient, ensure compliance of the patient/parents and to help sorting out possible side effects and interactions both for old and new AEDs. [14] [15] [16] Measurement of serum drug concentrations is especially important at the extremes of age, in this case in children with rapid changes in physiological and pharmacokinetic properties, to individualize the pharmacological therapy. 17 
Polytherapy
The majority of the children were using one or two AEDs, both at admission and at discharge. Some of the children were discharged with more AEDs than at admission. This may be due to ongoing drug adjustments; one drug is being tapered off and the new one is already introduced. Earlier studies at the centre have demonstrated that polytherapy is more common in adults than in children. 8 Paediatricians are perhaps especially concerned about polytherapy, as adverse effects may interfere with the children's quality of life. Some children may have a better life although still having some seizures. During polytherapy, it is important to focus upon the risk of pharmacokinetic interactions, as the most frequently used AEDs are susceptible for enzyme induction or inhibition. 18 In addition, a commonly used combination in adults, valproate and lamotrigine, has proven to give a synergistic pharmacodynamic effect. 
Comorbidity, seizure control and everyday life
Most patients with generalized/multifocal seizure types suffered from comorbid conditions, as did many of the children within the three other epilepsy categories. The high prevalence of comorbid conditions was accompanied by one-third of the patients being treated pharmacologically with other drugs, which in both directions may interact and affect their medical treatment. 20 Høie et al. 21 found that severe non-verbal problems were highly overrepresented in children with epilepsy, and that these deficits may Table 4 The most commonly occurring comorbid conditions among the children and relevant medication (n = 261). The number of patients is given in parenthesis.
be especially common in complex and therapy resistant epilepsies. They concluded that their findings could be useful for the followup team in developing therapy strategies to meet the individual needs of the child with epilepsy. This underlines the need for a comprehensive care approach to the individual child admitted to a referral centre like ours, and supports the integrated multidisciplinary services offered to our patients. The comprehensive care approach seems to benefit the patients; according to the parents, many of the children profited from the stay. Schachter 22 points out that the quality of life for patients with epilepsy is determined by many other aspects than seizure control, such as psychosocial factors, comorbidity and stigma. The parents' opinions about a better everyday life take these considerations into account. The use of AEDs, which include the practical handling of the medication and compliance was unchanged in most cases, but this may be due to the fact that the parents have had children with epilepsy for several years and are well educated regarding the treatment of their children and the importance of good compliance. 1 As most of the children referred to the centre are difficultto-treat patients, many with comorbid conditions, these results are encouraging. Epilepsy is a complex medical disorder, and the treatment should address many aspects. Studies have shown that a number of recommendations of care for epilepsy are not being met. 23, 24 The aim should be to eliminate or reduce both the medical and the social consequences of the disease.
Limitations of the study
The mean duration of a stay at the centre is short (8.4 days). This is partly due to the establishment of a short-stay ward. At this ward the children are mostly admitted for long-term video-EEG and possible optimalization of AED-treatment, and they are regularly re-admitted to the centre after three or four months for evaluation of their epilepsy. Even patients at the three other wards are regularly re-admitted to the centre, because of their difficult-totreat epilepsy.
Another reason for the short-stays at our centre is that all children are admitted with at least one parent. The parents are fully compensated for their loss of income, but nevertheless they prefer minimum absence from their work. It is also considered to be best for the children to be as short as possible away from their everyday life.
During a stay at the centre the withdrawal of a drug and the introduction of another may be initiated. Optimal doses and serum concentrations could not be identified for all patients, but the extent of dosage adjustments was rather focused upon in the study. The alterations will be carried through at home. The frequent re-admissions, or alternatively an appropriate follow-up by paediatricians/neurologists at home, still allow treatment of high quality.
The results of this study are nation-bound, and referral patterns may vary among Northern-Western countries. The part of the study evaluating the impact of a stay at a referral centre, implies several limitations: forty percent of the questionnaires were not returned. Common features of the 104 children whose parents did not reply were more polytherapy compared to the children of the replying parents. This may have led to a bias of the results. Those who returned the questionnaire may have been more content with the stay than those who did not. But as there are no differences as to which AEDs the children were using and no differences in comorbidity, it is probably not decisive for the study results.
Regarding the three months follow-up time, the aim was to evaluate the status of the children after a quite short period of time after their last stay, but at the same time, a sufficient period to be able to notice differences in adverse events and weekly/daily seizures. Children in rapid development need close follow-up, and a longer period was regarded to be too long to relate the results of a stay at the centre to the situation of the children. Since the policy at the centre is to offer frequent stays to the patients rather than one prolonged stay, there will be a continuous follow-up to avoid that the children will revert to previous seizure situation.
In conclusion, the present study demonstrates that at the referral centre for epilepsy new AEDs were used more frequently than older drugs in all age groups except the youngest children and in all seizure types except unspecified epilepsies. The study elucidates the impact of close follow-up of the children for optimalized treatment, as confirmed by the parents three months after the stay.
